These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 16949344
1. Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: a comparative short-term study. Ciesielski AS, Samson S, Steinhoff BJ. Epilepsy Behav; 2006 Nov; 9(3):424-31. PubMed ID: 16949344 [Abstract] [Full Text] [Related]
2. Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures. Zhou B, Zhang Q, Tian L, Xiao J, Stefan H, Zhou D. Epilepsy Behav; 2008 Feb; 12(2):305-10. PubMed ID: 18024209 [Abstract] [Full Text] [Related]
3. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials. Uthman BM, Almas M, Emir B, Giordano S, Leon T. Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392 [Abstract] [Full Text] [Related]
4. Comparative cognitive effects of levetiracetam and topiramate in intractable epilepsy. Huang CW, Pai MC, Tsai JJ. Psychiatry Clin Neurosci; 2008 Oct; 62(5):548-53. PubMed ID: 18950374 [Abstract] [Full Text] [Related]
6. Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses? Brodie MJ, Kelly K, Stephen LJ. Epilepsy Behav; 2014 Feb; 31():73-6. PubMed ID: 24361766 [Abstract] [Full Text] [Related]
7. The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate. Gomer B, Wagner K, Frings L, Saar J, Carius A, Härle M, Steinhoff BJ, Schulze-Bonhage A. Epilepsy Behav; 2007 May; 10(3):486-94. PubMed ID: 17409025 [Abstract] [Full Text] [Related]
8. Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy. Tanaka S, Tanaka T. Epileptic Disord; 2013 Jun; 15(2):132-41. PubMed ID: 23774199 [Abstract] [Full Text] [Related]
9. [Analysis of the cost-effectiveness of treatment for refractory partial epilepsy: a simulation model for pregabalin and levetiracetam]. Díaz S, Argumosa A, Horga de la Parte JF, Vera-Llonch M, Dukes E, Rejas-Gutiérrez J. Rev Neurol; 2013 Jun; 45(8):460-7. PubMed ID: 17948211 [Abstract] [Full Text] [Related]
10. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures. Wu XY, Hong Z, Wu X, Wu LW, Wang XF, Zhou D, Zhao ZX, Lv CZ. Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175 [Abstract] [Full Text] [Related]
13. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA). Stefan H, Wang-Tilz Y, Pauli E, Dennhöfer S, Genow A, Kerling F, Lorber B, Fraunberger B, Halboni P, Koebnick C, Gefeller O, Tilz C. Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615 [Abstract] [Full Text] [Related]
14. Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study. López-Góngora M, Martínez-Domeño A, García C, Escartín A. Epileptic Disord; 2008 Dec; 10(4):297-305. PubMed ID: 19017572 [Abstract] [Full Text] [Related]
15. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial. Peltola J, Coetzee C, Jiménez F, Litovchenko T, Ramaratnam S, Zaslavaskiy L, Lu ZS, Sykes DM, Levetiracetam XR N01235 Study Group. Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886 [Abstract] [Full Text] [Related]
16. Effects of levetiracetam on seizure frequency and neuropsychological impairments in children with refractory epilepsy with secondary bilateral synchrony. Kanemura H, Sano F, Sugita K, Aihara M. Seizure; 2013 Jan; 22(1):43-7. PubMed ID: 23127775 [Abstract] [Full Text] [Related]
18. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial. Levisohn PM, Mintz M, Hunter SJ, Yang H, Jones J, N01103 Levetiracetam Study Group. Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752 [Abstract] [Full Text] [Related]